title: Intrathoracic nontuberculous mycobacterial infections in otherwise healthy children.
abstract: Nontuberculous mycobacterial (NTM) infection is typically associated with lymphadenitis in immune competent children, and disseminated disease in children with immune deficiencies. Isolated pulmonary NTM disease is seen in cystic fibrosis, and is increasingly recognized in immunocompetent elderly women, where it is associated with an increased incidence of cystic fibrosis transmembrane regulator (CFTR) mutations. Thoracic NTM infection has been reported rarely in otherwise healthy children. We aimed to determine whether otherwise healthy children with pulmonary NTM disease had immunologic abnormalities or CFTR mutations. Clinical presentations of five otherwise healthy children with pulmonary NTM were reviewed. Immunologic studies were performed including a complete blood cell count (CBC), flow cytometric lymphocyte phenotyping and IFN-gamma receptor expression, in vitro cytokine stimulation, and serum immunoglobulin levels. Mutational analysis was performed for CFTR. The children ranged in age from 12 months to 2.5 years at diagnosis. Four presented with new onset wheezing or stridor failing bronchodilator therapy. One child was asymptomatic. Endobronchial lesions and/or hilar lymph nodes causing bronchial obstruction were identified in all patients. Mycobacterium avium complex was cultured from four patients, and Mycobacterium abscessus from one patient. All patients were successfully treated with anti-mycobacterial therapy with or without surgery. No definitive immunologic abnormalities were identified. No clinically significant mutations were found in CFTR. Pulmonary NTM infection should be considered in otherwise healthy young children presenting with refractory stridor or wheezing with endobronchial lesions or hilar lymphadenopathy. It does not appear to be associated with recognized underlying immune deficiency or CFTR mutations.
authors.affiliation: SAIC-Frederick, Inc, NCI-Frederick, Frederick, Maryland 27102, USA. freemaal@mail.nih.gov
authors.forename: Alexandra F
authors.initials: AF
authors.lastname: Freeman
authors.forename: Kenneth N
authors.initials: KN
authors.lastname: Olivier
authors.forename: Thomas T
authors.initials: TT
authors.lastname: Rubio
authors.forename: Glen
authors.initials: G
authors.lastname: Bartlett
authors.forename: James W
authors.initials: JW
authors.lastname: Ochi
authors.forename: Reginald J
authors.initials: RJ
authors.lastname: Claypool
authors.forename: Li
authors.initials: L
authors.lastname: Ding
authors.forename: Douglas B
authors.initials: DB
authors.lastname: Kuhns
authors.forename: Steven M
authors.initials: SM
authors.lastname: Holland
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use; D001999:Bronchoscopy; D002675:Child, Preschool; D006801:Humans; D007121:Immunocompetence; D007223:Infant; D008206:Lymphatic Diseases / Q000000981:diagnostic imaging*; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000276:immunology; D014057:Tomography, X-Ray Computed
chemical_list: D000995:Antitubercular Agents